Susana Banerjee, MBBS, MA, PhD - When Patients With Advanced Endometrial Cancer Progress: Decisions in Treatment Initiation and Optimisation

Visit https://www.peervoice.com/PAG860 to view the entire programme with slides. After completing “Susana Banerjee, MBBS, MA, PhD - When Patients With Advanced Endometrial Cancer Progress: Decisions in Treatment Initiation and Optimisation”, participants will be able to: Evaluate recent clinical data for new and emerging tyrosine kinase inhibitor and immunotherapy (TKI/IO) combination therapies in the management of endometrial cancer; Identify patients with advanced/recurrent endometrial cancer who may benefit from TKI/IO combination therapy; Apply appropriate strategies to optimise outcomes in patients with advanced endometrial cancer; and Discuss the importance of the multidisciplinary team and shared decision-making in the management of patients with advanced/recurrent endometrial cancer.